DAP:ETR
Danaher Corp
207,60 €
arrow_upward
+1,42%(+2,90) 1D
9 қар., 17:35:58 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DAP...
Open
209,60 €
High
209,60 €
Low
206,50 €
Mkt. cap
165,41 млрд
Avg. vol.
596,00
Volume
267,00
52-wk high
214,50 €
52-wk low
138,20 €
No. of employees
59 мың
Open
209,60 €
High
209,60 €
Low
206,50 €
Mkt. cap
165,41 млрд
Avg. vol.
596,00
Volume
267,00
52-wk high
214,50 €
52-wk low
138,20 €
No. of employees
59 мың
News stories
From web sources and news partners
Investing.com
·
5 сағат бұрын
Danaher at UBS Global Healthcare Conference: growth plan takes shape
Investing.com Canada
·
5 сағат бұрын
Form 144 DANAHER CORP /DE/ For: 9 November By Investing.com
MarketWatch
·
3 күн бұрын
Danaher Corp. stock underperforms Friday when compared to competitors despite daily gains
Profile
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
About Danaher Corp
CEORainer M. Blair
Employees59 мың
Founded1969
Headquarters-
SectorHealth Care
Industry-
Websitedanaher.com